#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=The brain's functional connectome in young children with prenatal alcohol exposure Highlights We used fMRI to study young children with prenatal alcohol exposure (PAE).
1-1	0-3	The	_
1-2	4-9	brain	_
1-3	10-12	's	_
1-4	13-23	functional	_
1-5	24-34	connectome	_
1-6	35-37	in	_
1-7	38-43	young	_
1-8	44-52	children	_
1-9	53-57	with	_
1-10	58-66	prenatal	_
1-11	67-74	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-12	75-83	exposure	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholAbuse
1-13	84-94	Highlights	_
1-14	95-97	We	_
1-15	98-102	used	_
1-16	103-107	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
1-17	108-110	to	_
1-18	111-116	study	_
1-19	117-122	young	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-20	123-131	children	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-21	132-136	with	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-22	137-145	prenatal	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-23	146-153	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-24	154-162	exposure	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-25	163-164	(	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-26	165-168	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-27	169-170	)	http://maven.renci.org/NeuroBridge/neurobridge#FetalAlcoholBehaviorScale
1-28	171-172	.	_

Text=We measured the functional connectome and its stability within and across participants.
2-1	173-175	We	_
2-2	176-184	measured	_
2-3	185-188	the	_
2-4	189-199	functional	_
2-5	200-210	connectome	_
2-6	211-214	and	_
2-7	215-218	its	_
2-8	219-228	stability	_
2-9	229-235	within	_
2-10	236-239	and	_
2-11	240-246	across	_
2-12	247-259	participants	_
2-13	260-261	.	_

Text=The PAE group had similar graph theory metrics to controls.
3-1	262-265	The	_
3-2	266-269	PAE	_
3-3	270-275	group	_
3-4	276-279	had	_
3-5	280-287	similar	_
3-6	288-293	graph	_
3-7	294-300	theory	_
3-8	301-308	metrics	_
3-9	309-311	to	_
3-10	312-320	controls	_
3-11	321-322	.	_

Text=The PAE group, but not controls, had increasing intra-participant stability with age.
4-1	323-326	The	_
4-2	327-330	PAE	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
4-3	331-336	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
4-4	337-338	,	_
4-5	339-342	but	_
4-6	343-346	not	_
4-7	347-355	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-8	356-357	,	_
4-9	358-361	had	_
4-10	362-372	increasing	_
4-11	373-390	intra-participant	_
4-12	391-400	stability	_
4-13	401-405	with	_
4-14	406-409	age	_
4-15	410-411	.	_

Text=Controls, but not the PAE group, had increasing inter-participant stability with age.
5-1	412-420	Controls	_
5-2	421-422	,	_
5-3	423-426	but	_
5-4	427-430	not	_
5-5	431-434	the	_
5-6	435-438	PAE	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
5-7	439-444	group	http://maven.renci.org/NeuroBridge/neurobridge#ParallelGroupTrial
5-8	445-446	,	_
5-9	447-450	had	_
5-10	451-461	increasing	_
5-11	462-479	inter-participant	_
5-12	480-489	stability	_
5-13	490-494	with	_
5-14	495-498	age	_
5-15	499-500	.	_

Text=Prenatal alcohol exposure (PAE) can lead to altered brain function and structure, as well as lifelong cognitive, behavioral, and mental health difficulties.
6-1	501-509	Prenatal	_
6-2	510-517	alcohol	_
6-3	518-526	exposure	_
6-4	527-528	(	_
6-5	529-532	PAE	_
6-6	533-534	)	_
6-7	535-538	can	_
6-8	539-543	lead	_
6-9	544-546	to	_
6-10	547-554	altered	_
6-11	555-560	brain	_
6-12	561-569	function	_
6-13	570-573	and	_
6-14	574-583	structure	_
6-15	584-585	,	_
6-16	586-588	as	_
6-17	589-593	well	_
6-18	594-596	as	_
6-19	597-605	lifelong	_
6-20	606-615	cognitive	_
6-21	616-617	,	_
6-22	618-628	behavioral	_
6-23	629-630	,	_
6-24	631-634	and	_
6-25	635-641	mental	_
6-26	642-648	health	_
6-27	649-661	difficulties	_
6-28	662-663	.	_

Text=Previous research has shown reduced brain network efficiency in older children and adolescents with PAE, but no imaging studies have examined brain differences in young children with PAE, at an age when cognitive and behavioral problems often first become apparent.
7-1	664-672	Previous	_
7-2	673-681	research	_
7-3	682-685	has	_
7-4	686-691	shown	_
7-5	692-699	reduced	_
7-6	700-705	brain	_
7-7	706-713	network	_
7-8	714-724	efficiency	_
7-9	725-727	in	_
7-10	728-733	older	_
7-11	734-742	children	_
7-12	743-746	and	_
7-13	747-758	adolescents	http://maven.renci.org/NeuroBridge/neurobridge#Cholesterol
7-14	759-763	with	_
7-15	764-767	PAE	http://maven.renci.org/NeuroBridge/neurobridge#Thing
7-16	768-769	,	_
7-17	770-773	but	_
7-18	774-776	no	_
7-19	777-784	imaging	_
7-20	785-792	studies	_
7-21	793-797	have	_
7-22	798-806	examined	_
7-23	807-812	brain	_
7-24	813-824	differences	_
7-25	825-827	in	_
7-26	828-833	young	_
7-27	834-842	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
7-28	843-847	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
7-29	848-851	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
7-30	852-853	,	_
7-31	854-856	at	_
7-32	857-859	an	_
7-33	860-863	age	_
7-34	864-868	when	_
7-35	869-878	cognitive	_
7-36	879-882	and	_
7-37	883-893	behavioral	_
7-38	894-902	problems	_
7-39	903-908	often	_
7-40	909-914	first	_
7-41	915-921	become	_
7-42	922-930	apparent	_
7-43	931-932	.	_

Text=The present study aimed to investigate the brain's functional connectome in young children with PAE using passive viewing fMRI.
8-1	933-936	The	_
8-2	937-944	present	_
8-3	945-950	study	_
8-4	951-956	aimed	_
8-5	957-959	to	_
8-6	960-971	investigate	_
8-7	972-975	the	_
8-8	976-981	brain	_
8-9	982-984	's	_
8-10	985-995	functional	_
8-11	996-1006	connectome	_
8-12	1007-1009	in	_
8-13	1010-1015	young	_
8-14	1016-1024	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
8-15	1025-1029	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
8-16	1030-1033	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
8-17	1034-1039	using	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
8-18	1040-1047	passive	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
8-19	1048-1055	viewing	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
8-20	1056-1060	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
8-21	1061-1062	.	_

Text=We analyzed 34 datasets from 26 children with PAE aged 2–7 years and 215 datasets from 87 unexposed typically-developing children in the same age range.
9-1	1063-1065	We	_
9-2	1066-1074	analyzed	_
9-3	1075-1077	34	_
9-4	1078-1086	datasets	_
9-5	1087-1091	from	_
9-6	1092-1094	26	_
9-7	1095-1103	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
9-8	1104-1108	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
9-9	1109-1112	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
9-10	1113-1117	aged	_
9-11	1118-1121	2–7	_
9-12	1122-1127	years	_
9-13	1128-1131	and	_
9-14	1132-1135	215	_
9-15	1136-1144	datasets	_
9-16	1145-1149	from	_
9-17	1150-1152	87	_
9-18	1153-1162	unexposed	_
9-19	1163-1183	typically-developing	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
9-20	1184-1192	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
9-21	1193-1195	in	_
9-22	1196-1199	the	_
9-23	1200-1204	same	_
9-24	1205-1208	age	_
9-25	1209-1214	range	_
9-26	1215-1216	.	_

Text=The whole brain functional connectome was constructed using functional connectivity analysis across 90 regions for each dataset.
10-1	1217-1220	The	_
10-2	1221-1226	whole	_
10-3	1227-1232	brain	_
10-4	1233-1243	functional	_
10-5	1244-1254	connectome	_
10-6	1255-1258	was	_
10-7	1259-1270	constructed	_
10-8	1271-1276	using	_
10-9	1277-1287	functional	_
10-10	1288-1300	connectivity	_
10-11	1301-1309	analysis	_
10-12	1310-1316	across	_
10-13	1317-1319	90	_
10-14	1320-1327	regions	_
10-15	1328-1331	for	_
10-16	1332-1336	each	_
10-17	1337-1344	dataset	_
10-18	1345-1346	.	_

Text=We examined intra- and inter-participant stability of the functional connectome, graph theoretical measurements, and their correlations with age.
11-1	1347-1349	We	_
11-2	1350-1358	examined	_
11-3	1359-1365	intra-	_
11-4	1366-1369	and	_
11-5	1370-1387	inter-participant	_
11-6	1388-1397	stability	_
11-7	1398-1400	of	_
11-8	1401-1404	the	_
11-9	1405-1415	functional	_
11-10	1416-1426	connectome	_
11-11	1427-1428	,	_
11-12	1429-1434	graph	_
11-13	1435-1446	theoretical	_
11-14	1447-1459	measurements	_
11-15	1460-1461	,	_
11-16	1462-1465	and	_
11-17	1466-1471	their	_
11-18	1472-1484	correlations	_
11-19	1485-1489	with	_
11-20	1490-1493	age	_
11-21	1494-1495	.	_

Text=Children with PAE had similar inter- and intra-participant stability to controls.
12-1	1496-1504	Children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
12-2	1505-1509	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
12-3	1510-1513	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
12-4	1514-1517	had	_
12-5	1518-1525	similar	_
12-6	1526-1532	inter-	_
12-7	1533-1536	and	_
12-8	1537-1554	intra-participant	_
12-9	1555-1564	stability	_
12-10	1565-1567	to	_
12-11	1568-1576	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-12	1577-1578	.	_

Text=However, children with PAE, but not controls, showed increasing intra-participant stability with age, suggesting a lack of variability of intrinsic brain activity over time.
13-1	1579-1586	However	_
13-2	1587-1588	,	_
13-3	1589-1597	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
13-4	1598-1602	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
13-5	1603-1606	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
13-6	1607-1608	,	_
13-7	1609-1612	but	_
13-8	1613-1616	not	_
13-9	1617-1625	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-10	1626-1627	,	_
13-11	1628-1634	showed	_
13-12	1635-1645	increasing	_
13-13	1646-1663	intra-participant	_
13-14	1664-1673	stability	_
13-15	1674-1678	with	_
13-16	1679-1682	age	_
13-17	1683-1684	,	_
13-18	1685-1695	suggesting	_
13-19	1696-1697	a	_
13-20	1698-1702	lack	_
13-21	1703-1705	of	_
13-22	1706-1717	variability	_
13-23	1718-1720	of	_
13-24	1721-1730	intrinsic	_
13-25	1731-1736	brain	_
13-26	1737-1745	activity	_
13-27	1746-1750	over	_
13-28	1751-1755	time	_
13-29	1756-1757	.	_

Text=Inter-participant stability increased with age in controls but not in children with PAE, indicating more variability of brain function across the PAE population.
14-1	1758-1775	Inter-participant	_
14-2	1776-1785	stability	_
14-3	1786-1795	increased	_
14-4	1796-1800	with	_
14-5	1801-1804	age	_
14-6	1805-1807	in	_
14-7	1808-1816	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
14-8	1817-1820	but	_
14-9	1821-1824	not	_
14-10	1825-1827	in	_
14-11	1828-1836	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
14-12	1837-1841	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
14-13	1842-1845	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
14-14	1846-1847	,	_
14-15	1848-1858	indicating	_
14-16	1859-1863	more	_
14-17	1864-1875	variability	_
14-18	1876-1878	of	_
14-19	1879-1884	brain	_
14-20	1885-1893	function	_
14-21	1894-1900	across	_
14-22	1901-1904	the	_
14-23	1905-1908	PAE	_
14-24	1909-1919	population	_
14-25	1920-1921	.	_

Text=Global graph metrics were similar between children with PAE and controls, in line with previous studies in older children.
15-1	1922-1928	Global	_
15-2	1929-1934	graph	_
15-3	1935-1942	metrics	_
15-4	1943-1947	were	_
15-5	1948-1955	similar	_
15-6	1956-1963	between	_
15-7	1964-1972	children	_
15-8	1973-1977	with	_
15-9	1978-1981	PAE	_
15-10	1982-1985	and	_
15-11	1986-1994	controls	_
15-12	1995-1996	,	_
15-13	1997-1999	in	_
15-14	2000-2004	line	_
15-15	2005-2009	with	_
15-16	2010-2018	previous	_
15-17	2019-2026	studies	_
15-18	2027-2029	in	_
15-19	2030-2035	older	_
15-20	2036-2044	children	_
15-21	2045-2046	.	_

Text=This study characterizes the functional connectome in young children with PAE for the first time, suggesting that the increased brain variability seen in older children develops early in childhood, when participants with PAE fail to show the expected age-related increases in inter-individual stability.
16-1	2047-2051	This	_
16-2	2052-2057	study	_
16-3	2058-2071	characterizes	_
16-4	2072-2075	the	_
16-5	2076-2086	functional	_
16-6	2087-2097	connectome	_
16-7	2098-2100	in	_
16-8	2101-2106	young	_
16-9	2107-2115	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
16-10	2116-2120	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
16-11	2121-2124	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
16-12	2125-2128	for	_
16-13	2129-2132	the	_
16-14	2133-2138	first	_
16-15	2139-2143	time	_
16-16	2144-2145	,	_
16-17	2146-2156	suggesting	_
16-18	2157-2161	that	_
16-19	2162-2165	the	_
16-20	2166-2175	increased	_
16-21	2176-2181	brain	_
16-22	2182-2193	variability	_
16-23	2194-2198	seen	_
16-24	2199-2201	in	_
16-25	2202-2207	older	_
16-26	2208-2216	children	_
16-27	2217-2225	develops	_
16-28	2226-2231	early	_
16-29	2232-2234	in	_
16-30	2235-2244	childhood	_
16-31	2245-2246	,	_
16-32	2247-2251	when	_
16-33	2252-2264	participants	_
16-34	2265-2269	with	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
16-35	2270-2273	PAE	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
16-36	2274-2278	fail	_
16-37	2279-2281	to	_
16-38	2282-2286	show	_
16-39	2287-2290	the	_
16-40	2291-2299	expected	_
16-41	2300-2311	age-related	_
16-42	2312-2321	increases	_
16-43	2322-2324	in	_
16-44	2325-2341	inter-individual	_
16-45	2342-2351	stability	_
16-46	2352-2353	.	_

Text=Materials and methods Participants This study recruited 52 children with PAE (26 males/26 females, aged 2.78 to 7.22 years) from Alberta, Canada.
17-1	2354-2363	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
17-2	2364-2367	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
17-3	2368-2375	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
17-4	2376-2388	Participants	_
17-5	2389-2393	This	_
17-6	2394-2399	study	_
17-7	2400-2409	recruited	_
17-8	2410-2412	52	_
17-9	2413-2421	children	_
17-10	2422-2426	with	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
17-11	2427-2430	PAE	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
17-12	2431-2432	(	_
17-13	2433-2435	26	_
17-14	2436-2444	males/26	_
17-15	2445-2452	females	_
17-16	2453-2454	,	_
17-17	2455-2459	aged	_
17-18	2460-2464	2.78	_
17-19	2465-2467	to	_
17-20	2468-2472	7.22	_
17-21	2473-2478	years	_
17-22	2479-2480	)	_
17-23	2481-2485	from	_
17-24	2486-2493	Alberta	_
17-25	2494-2495	,	_
17-26	2496-2502	Canada	_
17-27	2503-2504	.	_

Text=Participants with PAE were recruited via advertisements (print and online) in newsletters and parent groups (n = 18), early intervention services and diagnostic clinics (n = 25), and through Child and Family Services (n = 9).
18-1	2505-2517	Participants	_
18-2	2518-2522	with	_
18-3	2523-2526	PAE	http://maven.renci.org/NeuroBridge/neurobridge#Thing
18-4	2527-2531	were	_
18-5	2532-2541	recruited	_
18-6	2542-2545	via	_
18-7	2546-2560	advertisements	_
18-8	2561-2562	(	_
18-9	2563-2568	print	_
18-10	2569-2572	and	_
18-11	2573-2579	online	_
18-12	2580-2581	)	_
18-13	2582-2584	in	_
18-14	2585-2596	newsletters	_
18-15	2597-2600	and	_
18-16	2601-2607	parent	_
18-17	2608-2614	groups	_
18-18	2615-2616	(	_
18-19	2617-2618	n	_
18-20	2619-2620	=	_
18-21	2621-2623	18	_
18-22	2624-2625	)	_
18-23	2626-2627	,	_
18-24	2628-2633	early	_
18-25	2634-2646	intervention	_
18-26	2647-2655	services	_
18-27	2656-2659	and	_
18-28	2660-2670	diagnostic	_
18-29	2671-2678	clinics	_
18-30	2679-2680	(	_
18-31	2681-2682	n	_
18-32	2683-2684	=	_
18-33	2685-2687	25	_
18-34	2688-2689	)	_
18-35	2690-2691	,	_
18-36	2692-2695	and	_
18-37	2696-2703	through	_
18-38	2704-2709	Child	_
18-39	2710-2713	and	_
18-40	2714-2720	Family	_
18-41	2721-2729	Services	_
18-42	2730-2731	(	_
18-43	2732-2733	n	_
18-44	2734-2735	=	_
18-45	2736-2737	9	_
18-46	2738-2739	)	_
18-47	2740-2741	.	_

Text=PAE was confirmed via child welfare files (containing information from birth families), social workers, police records, medical files, and semi-structured interviews with caregivers and birth families, where possible.
19-1	2742-2745	PAE	_
19-2	2746-2749	was	_
19-3	2750-2759	confirmed	_
19-4	2760-2763	via	_
19-5	2764-2769	child	_
19-6	2770-2777	welfare	_
19-7	2778-2783	files	_
19-8	2784-2785	(	_
19-9	2786-2796	containing	_
19-10	2797-2808	information	_
19-11	2809-2813	from	_
19-12	2814-2819	birth	_
19-13	2820-2828	families	_
19-14	2829-2830	)	_
19-15	2831-2832	,	_
19-16	2833-2839	social	_
19-17	2840-2847	workers	_
19-18	2848-2849	,	_
19-19	2850-2856	police	_
19-20	2857-2864	records	_
19-21	2865-2866	,	_
19-22	2867-2874	medical	_
19-23	2875-2880	files	_
19-24	2881-2882	,	_
19-25	2883-2886	and	_
19-26	2887-2902	semi-structured	_
19-27	2903-2913	interviews	_
19-28	2914-2918	with	_
19-29	2919-2929	caregivers	_
19-30	2930-2933	and	_
19-31	2934-2939	birth	_
19-32	2940-2948	families	_
19-33	2949-2950	,	_
19-34	2951-2956	where	_
19-35	2957-2965	possible	_
19-36	2966-2967	.	_

Text=No participants had been diagnosed with fetal alcohol spectrum disorder (FASD), the developmental disorder associated with PAE, because they are too young to be assessed in most diagnostic clinics in Alberta, which typically see children only after they are 7-years old.
20-1	2968-2970	No	_
20-2	2971-2983	participants	_
20-3	2984-2987	had	_
20-4	2988-2992	been	_
20-5	2993-3002	diagnosed	_
20-6	3003-3007	with	_
20-7	3008-3013	fetal	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-8	3014-3021	alcohol	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-9	3022-3030	spectrum	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-10	3031-3039	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-11	3040-3041	(	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-12	3042-3046	FASD	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-13	3047-3048	)	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
20-14	3049-3050	,	_
20-15	3051-3054	the	_
20-16	3055-3068	developmental	_
20-17	3069-3077	disorder	_
20-18	3078-3088	associated	_
20-19	3089-3093	with	_
20-20	3094-3097	PAE	http://maven.renci.org/NeuroBridge/neurobridge#Thing
20-21	3098-3099	,	_
20-22	3100-3107	because	_
20-23	3108-3112	they	_
20-24	3113-3116	are	_
20-25	3117-3120	too	_
20-26	3121-3126	young	_
20-27	3127-3129	to	_
20-28	3130-3132	be	_
20-29	3133-3141	assessed	_
20-30	3142-3144	in	_
20-31	3145-3149	most	_
20-32	3150-3160	diagnostic	_
20-33	3161-3168	clinics	_
20-34	3169-3171	in	_
20-35	3172-3179	Alberta	_
20-36	3180-3181	,	_
20-37	3182-3187	which	_
20-38	3188-3197	typically	_
20-39	3198-3201	see	_
20-40	3202-3210	children	_
20-41	3211-3215	only	_
20-42	3216-3221	after	_
20-43	3222-3226	they	_
20-44	3227-3230	are	_
20-45	3231-3238	7-years	_
20-46	3239-3242	old	_
20-47	3243-3244	.	_

Text=153 unexposed typically-developing children (82 males/71 females; aged 1.97 to 8.04 years) were included from an ongoing study of typical brain development.
21-1	3245-3248	153	_
21-2	3249-3258	unexposed	_
21-3	3259-3279	typically-developing	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
21-4	3280-3288	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
21-5	3289-3290	(	_
21-6	3291-3293	82	_
21-7	3294-3302	males/71	_
21-8	3303-3310	females	_
21-9	3311-3312	;	_
21-10	3313-3317	aged	_
21-11	3318-3322	1.97	_
21-12	3323-3325	to	_
21-13	3326-3330	8.04	_
21-14	3331-3336	years	_
21-15	3337-3338	)	_
21-16	3339-3343	were	_
21-17	3344-3352	included	_
21-18	3353-3357	from	_
21-19	3358-3360	an	_
21-20	3361-3368	ongoing	_
21-21	3369-3374	study	_
21-22	3375-3377	of	_
21-23	3378-3385	typical	_
21-24	3386-3391	brain	_
21-25	3392-3403	development	_
21-26	3404-3405	.	_

Text=These typically-developing controls were originally recruited from the Calgary community via advertisements and from the Alberta Pregnancy Outcomes and Nutrition (APrON) study, an ongoing research study that recruited women in pregnancy and is focused on child outcomes related to maternal nutrition and mental health in pregnancy.
22-1	3406-3411	These	_
22-2	3412-3432	typically-developing	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
22-3	3433-3441	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
22-4	3442-3446	were	_
22-5	3447-3457	originally	_
22-6	3458-3467	recruited	_
22-7	3468-3472	from	_
22-8	3473-3476	the	_
22-9	3477-3484	Calgary	_
22-10	3485-3494	community	_
22-11	3495-3498	via	_
22-12	3499-3513	advertisements	_
22-13	3514-3517	and	_
22-14	3518-3522	from	_
22-15	3523-3526	the	_
22-16	3527-3534	Alberta	_
22-17	3535-3544	Pregnancy	_
22-18	3545-3553	Outcomes	_
22-19	3554-3557	and	_
22-20	3558-3567	Nutrition	http://maven.renci.org/NeuroBridge/neurobridge#NutritionQuestionnaire
22-21	3568-3569	(	_
22-22	3570-3575	APrON	_
22-23	3576-3577	)	_
22-24	3578-3583	study	_
22-25	3584-3585	,	_
22-26	3586-3588	an	_
22-27	3589-3596	ongoing	_
22-28	3597-3605	research	_
22-29	3606-3611	study	_
22-30	3612-3616	that	_
22-31	3617-3626	recruited	_
22-32	3627-3632	women	_
22-33	3633-3635	in	_
22-34	3636-3645	pregnancy	_
22-35	3646-3649	and	_
22-36	3650-3652	is	_
22-37	3653-3660	focused	_
22-38	3661-3663	on	_
22-39	3664-3669	child	_
22-40	3670-3678	outcomes	_
22-41	3679-3686	related	_
22-42	3687-3689	to	_
22-43	3690-3698	maternal	_
22-44	3699-3708	nutrition	_
22-45	3709-3712	and	_
22-46	3713-3719	mental	_
22-47	3720-3726	health	_
22-48	3727-3729	in	_
22-49	3730-3739	pregnancy	_
22-50	3740-3741	.	_

Text=For recruitment details for the APrON study, please refer to.
23-1	3742-3745	For	_
23-2	3746-3757	recruitment	_
23-3	3758-3765	details	_
23-4	3766-3769	for	_
23-5	3770-3773	the	_
23-6	3774-3779	APrON	_
23-7	3780-3785	study	_
23-8	3786-3787	,	_
23-9	3788-3794	please	_
23-10	3795-3800	refer	_
23-11	3801-3803	to	_
23-12	3804-3805	.	_

Text=The absence of prenatal alcohol exposure in controls was verified by maternal report at multiple stages of pregnancy.
24-1	3806-3809	The	_
24-2	3810-3817	absence	_
24-3	3818-3820	of	_
24-4	3821-3829	prenatal	_
24-5	3830-3837	alcohol	_
24-6	3838-3846	exposure	_
24-7	3847-3849	in	_
24-8	3850-3858	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
24-9	3859-3862	was	_
24-10	3863-3871	verified	_
24-11	3872-3874	by	_
24-12	3875-3883	maternal	_
24-13	3884-3890	report	_
24-14	3891-3893	at	_
24-15	3894-3902	multiple	_
24-16	3903-3909	stages	_
24-17	3910-3912	of	_
24-18	3913-3922	pregnancy	_
24-19	3923-3924	.	_

Text=The study was originally planned with a longitudinal design, and all participants ’ families were invited to return for subsequent scans approximately every six months before school age, and annually thereafter.
25-1	3925-3928	The	_
25-2	3929-3934	study	_
25-3	3935-3938	was	_
25-4	3939-3949	originally	_
25-5	3950-3957	planned	_
25-6	3958-3962	with	_
25-7	3963-3964	a	_
25-8	3965-3977	longitudinal	_
25-9	3978-3984	design	_
25-10	3985-3986	,	_
25-11	3987-3990	and	_
25-12	3991-3994	all	_
25-13	3995-4007	participants	_
25-14	4008-4009	’	_
25-15	4010-4018	families	_
25-16	4019-4023	were	_
25-17	4024-4031	invited	_
25-18	4032-4034	to	_
25-19	4035-4041	return	_
25-20	4042-4045	for	_
25-21	4046-4056	subsequent	_
25-22	4057-4062	scans	_
25-23	4063-4076	approximately	_
25-24	4077-4082	every	_
25-25	4083-4086	six	_
25-26	4087-4093	months	_
25-27	4094-4100	before	_
25-28	4101-4107	school	_
25-29	4108-4111	age	_
25-30	4112-4113	,	_
25-31	4114-4117	and	_
25-32	4118-4126	annually	_
25-33	4127-4137	thereafter	_
25-34	4138-4139	.	_

Text=After removing scans with severe head motion (see details in Data preprocessing), unfinished scans (any fMRI scans with <250 vol), and scans where participants were asleep, a total of 249 fMRI datasets (215 datasets from 87 control participants, 34 datasets from 26 participants with PAE, less head motion, non-sleep and full 250 vol) were included in the present study (Table 1).
26-1	4140-4145	After	_
26-2	4146-4154	removing	_
26-3	4155-4160	scans	_
26-4	4161-4165	with	_
26-5	4166-4172	severe	_
26-6	4173-4177	head	_
26-7	4178-4184	motion	_
26-8	4185-4186	(	_
26-9	4187-4190	see	_
26-10	4191-4198	details	_
26-11	4199-4201	in	_
26-12	4202-4206	Data	_
26-13	4207-4220	preprocessing	_
26-14	4221-4222	)	_
26-15	4223-4224	,	_
26-16	4225-4235	unfinished	_
26-17	4236-4241	scans	_
26-18	4242-4243	(	_
26-19	4244-4247	any	_
26-20	4248-4252	fMRI	_
26-21	4253-4258	scans	_
26-22	4259-4263	with	_
26-23	4264-4265	<	_
26-24	4266-4269	250	_
26-25	4270-4273	vol	_
26-26	4274-4275	)	_
26-27	4276-4277	,	_
26-28	4278-4281	and	_
26-29	4282-4287	scans	_
26-30	4288-4293	where	_
26-31	4294-4306	participants	_
26-32	4307-4311	were	_
26-33	4312-4318	asleep	_
26-34	4319-4320	,	_
26-35	4321-4322	a	_
26-36	4323-4328	total	_
26-37	4329-4331	of	_
26-38	4332-4335	249	_
26-39	4336-4340	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-40	4341-4349	datasets	_
26-41	4350-4351	(	_
26-42	4352-4355	215	_
26-43	4356-4364	datasets	_
26-44	4365-4369	from	_
26-45	4370-4372	87	_
26-46	4373-4380	control	_
26-47	4381-4393	participants	_
26-48	4394-4395	,	_
26-49	4396-4398	34	_
26-50	4399-4407	datasets	_
26-51	4408-4412	from	_
26-52	4413-4415	26	_
26-53	4416-4428	participants	_
26-54	4429-4433	with	_
26-55	4434-4437	PAE	_
26-56	4438-4439	,	_
26-57	4440-4444	less	_
26-58	4445-4449	head	_
26-59	4450-4456	motion	_
26-60	4457-4458	,	_
26-61	4459-4468	non-sleep	_
26-62	4469-4472	and	_
26-63	4473-4477	full	_
26-64	4478-4481	250	_
26-65	4482-4485	vol	_
26-66	4486-4487	)	_
26-67	4488-4492	were	_
26-68	4493-4501	included	_
26-69	4502-4504	in	_
26-70	4505-4508	the	_
26-71	4509-4516	present	_
26-72	4517-4522	study	_
26-73	4523-4524	(	_
26-74	4525-4530	Table	_
26-75	4531-4532	1	_
26-76	4533-4534	)	_
26-77	4535-4536	.	_

Text=Because data collection from the children with PAE began after the control data collection, fewer participants with PAE had multiple scans.
27-1	4537-4544	Because	_
27-2	4545-4549	data	_
27-3	4550-4560	collection	_
27-4	4561-4565	from	_
27-5	4566-4569	the	_
27-6	4570-4578	children	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
27-7	4579-4583	with	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
27-8	4584-4587	PAE	http://maven.renci.org/NeuroBridge/neurobridge#FrustrationEmotionTaskforChildren
27-9	4588-4593	began	_
27-10	4594-4599	after	_
27-11	4600-4603	the	_
27-12	4604-4611	control	_
27-13	4612-4616	data	_
27-14	4617-4627	collection	_
27-15	4628-4629	,	_
27-16	4630-4635	fewer	_
27-17	4636-4648	participants	_
27-18	4649-4653	with	_
27-19	4654-4657	PAE	_
27-20	4658-4661	had	_
27-21	4662-4670	multiple	_
27-22	4671-4676	scans	_
27-23	4677-4678	.	_

Text=Parents or legal guardians of all participants provided written informed consent, and all participants provided verbal assent.
28-1	4679-4686	Parents	_
28-2	4687-4689	or	_
28-3	4690-4695	legal	_
28-4	4696-4705	guardians	_
28-5	4706-4708	of	_
28-6	4709-4712	all	_
28-7	4713-4725	participants	_
28-8	4726-4734	provided	_
28-9	4735-4742	written	_
28-10	4743-4751	informed	_
28-11	4752-4759	consent	_
28-12	4760-4761	,	_
28-13	4762-4765	and	_
28-14	4766-4769	all	_
28-15	4770-4782	participants	_
28-16	4783-4791	provided	_
28-17	4792-4798	verbal	_
28-18	4799-4805	assent	_
28-19	4806-4807	.	_

Text=The study was approved by the conjoint health research ethics board at the University of Calgary.
29-1	4808-4811	The	_
29-2	4812-4817	study	_
29-3	4818-4821	was	_
29-4	4822-4830	approved	_
29-5	4831-4833	by	_
29-6	4834-4837	the	_
29-7	4838-4846	conjoint	_
29-8	4847-4853	health	_
29-9	4854-4862	research	_
29-10	4863-4869	ethics	_
29-11	4870-4875	board	_
29-12	4876-4878	at	_
29-13	4879-4882	the	_
29-14	4883-4893	University	_
29-15	4894-4896	of	_
29-16	4897-4904	Calgary	_
29-17	4905-4906	.	_

Text=MRI parameters Imaging was conducted on a GE 3T MR750w (General Electric, Waukesha, WI) scanner equipped with a 32-channel head-coil at the Alberta Children ’ s Hospital in Calgary, Canada.
30-1	4907-4910	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
30-2	4911-4921	parameters	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
30-3	4922-4929	Imaging	_
30-4	4930-4933	was	_
30-5	4934-4943	conducted	_
30-6	4944-4946	on	_
30-7	4947-4948	a	_
30-8	4949-4951	GE	_
30-9	4952-4954	3T	http://maven.renci.org/NeuroBridge/neurobridge#Thing
30-10	4955-4961	MR750w	http://maven.renci.org/NeuroBridge/neurobridge#Thing
30-11	4962-4963	(	_
30-12	4964-4971	General	_
30-13	4972-4980	Electric	_
30-14	4981-4982	,	_
30-15	4983-4991	Waukesha	_
30-16	4992-4993	,	_
30-17	4994-4996	WI	_
30-18	4997-4998	)	_
30-19	4999-5006	scanner	_
30-20	5007-5015	equipped	_
30-21	5016-5020	with	_
30-22	5021-5022	a	_
30-23	5023-5033	32-channel	_
30-24	5034-5043	head-coil	_
30-25	5044-5046	at	_
30-26	5047-5050	the	_
30-27	5051-5058	Alberta	_
30-28	5059-5067	Children	_
30-29	5068-5069	’	_
30-30	5070-5071	s	_
30-31	5072-5080	Hospital	_
30-32	5081-5083	in	_
30-33	5084-5091	Calgary	_
30-34	5092-5093	,	_
30-35	5094-5100	Canada	_
30-36	5101-5102	.	_

Text=Children were not sedated, and were watching a movie of their choice for the entire duration of the MRI scan.
31-1	5103-5111	Children	_
31-2	5112-5116	were	_
31-3	5117-5120	not	_
31-4	5121-5128	sedated	_
31-5	5129-5130	,	_
31-6	5131-5134	and	_
31-7	5135-5139	were	_
31-8	5140-5148	watching	_
31-9	5149-5150	a	_
31-10	5151-5156	movie	_
31-11	5157-5159	of	_
31-12	5160-5165	their	_
31-13	5166-5172	choice	_
31-14	5173-5176	for	_
31-15	5177-5180	the	_
31-16	5181-5187	entire	_
31-17	5188-5196	duration	_
31-18	5197-5199	of	_
31-19	5200-5203	the	_
31-20	5204-5207	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
31-21	5208-5212	scan	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImagingInstrument
31-22	5213-5214	.	_

Text=Headphones were equipped to receive movie audio and to communicate with scanning staff.
32-1	5215-5225	Headphones	_
32-2	5226-5230	were	_
32-3	5231-5239	equipped	_
32-4	5240-5242	to	_
32-5	5243-5250	receive	_
32-6	5251-5256	movie	_
32-7	5257-5262	audio	_
32-8	5263-5266	and	_
32-9	5267-5269	to	_
32-10	5270-5281	communicate	_
32-11	5282-5286	with	_
32-12	5287-5295	scanning	_
32-13	5296-5301	staff	_
32-14	5302-5303	.	_

Text=T1-weighted data acquisition used an FSPGR BRAVO sequence with flip angle = 12º, 210 slices, TR = 8.23 ms, TE = 3.76 ms, voxel size = 0.9 × 0.9 × 0.9 mm, matrix size = 512 × 512, inversion time = 540 ms. Data acquisition for fMRI used a gradient- echo-planar imaging (EPI) sequence with TR = 2 s, TE = 30 ms, flip angle = 60º, 36 slices, voxel size = 3.59 × 3.59 × 3.6 mm, matrix size = 64 × 64, 250 vol, total scan time 8:10 min.
33-1	5304-5315	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-2	5316-5320	data	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-3	5321-5332	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
33-4	5333-5337	used	_
33-5	5338-5340	an	_
33-6	5341-5346	FSPGR	http://maven.renci.org/NeuroBridge/neurobridge#GravesDisease
33-7	5347-5352	BRAVO	http://maven.renci.org/NeuroBridge/neurobridge#GravesDisease
33-8	5353-5361	sequence	_
33-9	5362-5366	with	_
33-10	5367-5371	flip	_
33-11	5372-5377	angle	_
33-12	5378-5379	=	_
33-13	5380-5383	12º	_
33-14	5384-5385	,	_
33-15	5386-5389	210	_
33-16	5390-5396	slices	_
33-17	5397-5398	,	_
33-18	5399-5401	TR	_
33-19	5402-5403	=	_
33-20	5404-5408	8.23	_
33-21	5409-5411	ms	_
33-22	5412-5413	,	_
33-23	5414-5416	TE	_
33-24	5417-5418	=	_
33-25	5419-5423	3.76	_
33-26	5424-5426	ms	_
33-27	5427-5428	,	_
33-28	5429-5434	voxel	_
33-29	5435-5439	size	_
33-30	5440-5441	=	_
33-31	5442-5445	0.9	_
33-32	5446-5447	×	_
33-33	5448-5451	0.9	_
33-34	5452-5453	×	_
33-35	5454-5457	0.9	_
33-36	5458-5460	mm	_
33-37	5461-5462	,	_
33-38	5463-5469	matrix	_
33-39	5470-5474	size	_
33-40	5475-5476	=	_
33-41	5477-5480	512	_
33-42	5481-5482	×	_
33-43	5483-5486	512	_
33-44	5487-5488	,	_
33-45	5489-5498	inversion	_
33-46	5499-5503	time	_
33-47	5504-5505	=	_
33-48	5506-5509	540	_
33-49	5510-5513	ms.	_
33-50	5514-5518	Data	_
33-51	5519-5530	acquisition	_
33-52	5531-5534	for	_
33-53	5535-5539	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
33-54	5540-5544	used	_
33-55	5545-5546	a	_
33-56	5547-5556	gradient-	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
33-57	5557-5568	echo-planar	_
33-58	5569-5576	imaging	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
33-59	5577-5578	(	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
33-60	5579-5582	EPI	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
33-61	5583-5584	)	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
33-62	5585-5593	sequence	http://maven.renci.org/NeuroBridge/neurobridge#ImagingModality
33-63	5594-5598	with	_
33-64	5599-5601	TR	_
33-65	5602-5603	=	_
33-66	5604-5605	2	_
33-67	5606-5607	s	_
33-68	5608-5609	,	_
33-69	5610-5612	TE	_
33-70	5613-5614	=	_
33-71	5615-5617	30	_
33-72	5618-5620	ms	_
33-73	5621-5622	,	_
33-74	5623-5627	flip	_
33-75	5628-5633	angle	_
33-76	5634-5635	=	_
33-77	5636-5639	60º	_
33-78	5640-5641	,	_
33-79	5642-5644	36	_
33-80	5645-5651	slices	_
33-81	5652-5653	,	_
33-82	5654-5659	voxel	_
33-83	5660-5664	size	_
33-84	5665-5666	=	_
33-85	5667-5671	3.59	_
33-86	5672-5673	×	_
33-87	5674-5678	3.59	_
33-88	5679-5680	×	_
33-89	5681-5684	3.6	_
33-90	5685-5687	mm	_
33-91	5688-5689	,	_
33-92	5690-5696	matrix	_
33-93	5697-5701	size	_
33-94	5702-5703	=	_
33-95	5704-5706	64	_
33-96	5707-5708	×	_
33-97	5709-5711	64	_
33-98	5712-5713	,	_
33-99	5714-5717	250	_
33-100	5718-5721	vol	_
33-101	5722-5723	,	_
33-102	5724-5729	total	_
33-103	5730-5734	scan	_
33-104	5735-5739	time	_
33-105	5740-5744	8:10	_
33-106	5745-5748	min	_
33-107	5749-5750	.	_

Text=The entire protocol including other modalities lasted 45–60 min, depending on whether sequences needed to be repeated.
34-1	5751-5754	The	_
34-2	5755-5761	entire	_
34-3	5762-5770	protocol	_
34-4	5771-5780	including	_
34-5	5781-5786	other	_
34-6	5787-5797	modalities	_
34-7	5798-5804	lasted	_
34-8	5805-5810	45–60	_
34-9	5811-5814	min	_
34-10	5815-5816	,	_
34-11	5817-5826	depending	_
34-12	5827-5829	on	_
34-13	5830-5837	whether	_
34-14	5838-5847	sequences	_
34-15	5848-5854	needed	_
34-16	5855-5857	to	_
34-17	5858-5860	be	_
34-18	5861-5869	repeated	_
34-19	5870-5871	.	_

Text=In some cases, children requested that the scan be stopped, or they were moving too much to collect high quality data, and the scan was stopped early.
35-1	5872-5874	In	_
35-2	5875-5879	some	_
35-3	5880-5885	cases	_
35-4	5886-5887	,	_
35-5	5888-5896	children	_
35-6	5897-5906	requested	_
35-7	5907-5911	that	_
35-8	5912-5915	the	_
35-9	5916-5920	scan	_
35-10	5921-5923	be	_
35-11	5924-5931	stopped	_
35-12	5932-5933	,	_
35-13	5934-5936	or	_
35-14	5937-5941	they	_
35-15	5942-5946	were	_
35-16	5947-5953	moving	_
35-17	5954-5957	too	_
35-18	5958-5962	much	_
35-19	5963-5965	to	_
35-20	5966-5973	collect	_
35-21	5974-5978	high	_
35-22	5979-5986	quality	_
35-23	5987-5991	data	_
35-24	5992-5993	,	_
35-25	5994-5997	and	_
35-26	5998-6001	the	_
35-27	6002-6006	scan	_
35-28	6007-6010	was	_
35-29	6011-6018	stopped	_
35-30	6019-6024	early	_
35-31	6025-6026	.	_

Text=Data preprocessing Data preprocessing was completed in AFNI and FSL.
36-1	6027-6031	Data	_
36-2	6032-6045	preprocessing	_
36-3	6046-6050	Data	_
36-4	6051-6064	preprocessing	_
36-5	6065-6068	was	_
36-6	6069-6078	completed	_
36-7	6079-6081	in	_
36-8	6082-6086	AFNI	_
36-9	6087-6090	and	_
36-10	6091-6094	FSL	_
36-11	6095-6096	.	_

Text=Each participant's T1-weighted image was skull stripped and segmented into gray matter, white matter, and cerebrospinal fluid (CSF) images and co-registered to their individual fMRI space.
37-1	6097-6101	Each	_
37-2	6102-6113	participant	http://maven.renci.org/NeuroBridge/neurobridge#Thing
37-3	6114-6116	's	_
37-4	6117-6128	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-5	6129-6134	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
37-6	6135-6138	was	_
37-7	6139-6144	skull	_
37-8	6145-6153	stripped	_
37-9	6154-6157	and	_
37-10	6158-6167	segmented	_
37-11	6168-6172	into	_
37-12	6173-6177	gray	_
37-13	6178-6184	matter	_
37-14	6185-6186	,	_
37-15	6187-6192	white	_
37-16	6193-6199	matter	_
37-17	6200-6201	,	_
37-18	6202-6205	and	_
37-19	6206-6219	cerebrospinal	_
37-20	6220-6225	fluid	_
37-21	6226-6227	(	_
37-22	6228-6231	CSF	_
37-23	6232-6233	)	_
37-24	6234-6240	images	_
37-25	6241-6244	and	_
37-26	6245-6258	co-registered	_
37-27	6259-6261	to	_
37-28	6262-6267	their	_
37-29	6268-6278	individual	_
37-30	6279-6283	fMRI	_
37-31	6284-6289	space	_
37-32	6290-6291	.	_

Text=Total brain volume was calculated as the sum of gray and white matter volumes and used as a covariate due to its potential effect on the graph measures.
38-1	6292-6297	Total	_
38-2	6298-6303	brain	_
38-3	6304-6310	volume	_
38-4	6311-6314	was	_
38-5	6315-6325	calculated	_
38-6	6326-6328	as	_
38-7	6329-6332	the	_
38-8	6333-6336	sum	_
38-9	6337-6339	of	_
38-10	6340-6344	gray	_
38-11	6345-6348	and	_
38-12	6349-6354	white	_
38-13	6355-6361	matter	_
38-14	6362-6369	volumes	_
38-15	6370-6373	and	_
38-16	6374-6378	used	_
38-17	6379-6381	as	_
38-18	6382-6383	a	_
38-19	6384-6393	covariate	_
38-20	6394-6397	due	_
38-21	6398-6400	to	_
38-22	6401-6404	its	_
38-23	6405-6414	potential	_
38-24	6415-6421	effect	_
38-25	6422-6424	on	_
38-26	6425-6428	the	_
38-27	6429-6434	graph	_
38-28	6435-6443	measures	_
38-29	6444-6445	.	_

Text=The first 10 volumes of the passive viewing fMRI data were removed to allow for environmental adaptation and signal stabilization; 240 volumes remained.
39-1	6446-6449	The	_
39-2	6450-6455	first	_
39-3	6456-6458	10	_
39-4	6459-6466	volumes	_
39-5	6467-6469	of	_
39-6	6470-6473	the	_
39-7	6474-6481	passive	_
39-8	6482-6489	viewing	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
39-9	6490-6494	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
39-10	6495-6499	data	_
39-11	6500-6504	were	_
39-12	6505-6512	removed	_
39-13	6513-6515	to	_
39-14	6516-6521	allow	_
39-15	6522-6525	for	_
39-16	6526-6539	environmental	_
39-17	6540-6550	adaptation	_
39-18	6551-6554	and	_
39-19	6555-6561	signal	_
39-20	6562-6575	stabilization	_
39-21	6576-6577	;	_
39-22	6578-6581	240	_
39-23	6582-6589	volumes	_
39-24	6590-6598	remained	_
39-25	6599-6600	.	_

Text=Correction of slice timing and head motion were performed.
40-1	6601-6611	Correction	_
40-2	6612-6614	of	_
40-3	6615-6620	slice	_
40-4	6621-6627	timing	_
40-5	6628-6631	and	_
40-6	6632-6636	head	_
40-7	6637-6643	motion	_
40-8	6644-6648	were	_
40-9	6649-6658	performed	_
40-10	6659-6660	.	_

Text=The averaged relative frame-wise displacement (FD) was calculated for further analysis.
41-1	6661-6664	The	_
41-2	6665-6673	averaged	_
41-3	6674-6682	relative	_
41-4	6683-6693	frame-wise	_
41-5	6694-6706	displacement	_
41-6	6707-6708	(	_
41-7	6709-6711	FD	_
41-8	6712-6713	)	_
41-9	6714-6717	was	_
41-10	6718-6728	calculated	_
41-11	6729-6732	for	_
41-12	6733-6740	further	_
41-13	6741-6749	analysis	_
41-14	6750-6751	.	_

Text=A 36-parameter matrix was created from the averaged signals from the individual whole brain mask, CSF mask, white matter mask, the six head motion parameters, and their temporal derivatives and quadratic term signals.
42-1	6752-6753	A	_
42-2	6754-6766	36-parameter	_
42-3	6767-6773	matrix	_
42-4	6774-6777	was	_
42-5	6778-6785	created	_
42-6	6786-6790	from	_
42-7	6791-6794	the	_
42-8	6795-6803	averaged	_
42-9	6804-6811	signals	_
42-10	6812-6816	from	_
42-11	6817-6820	the	_
42-12	6821-6831	individual	_
42-13	6832-6837	whole	_
42-14	6838-6843	brain	_
42-15	6844-6848	mask	_
42-16	6849-6850	,	_
42-17	6851-6854	CSF	_
42-18	6855-6859	mask	_
42-19	6860-6861	,	_
42-20	6862-6867	white	_
42-21	6868-6874	matter	_
42-22	6875-6879	mask	_
42-23	6880-6881	,	_
42-24	6882-6885	the	_
42-25	6886-6889	six	_
42-26	6890-6894	head	_
42-27	6895-6901	motion	_
42-28	6902-6912	parameters	_
42-29	6913-6914	,	_
42-30	6915-6918	and	_
42-31	6919-6924	their	_
42-32	6925-6933	temporal	_
42-33	6934-6945	derivatives	_
42-34	6946-6949	and	_
42-35	6950-6959	quadratic	_
42-36	6960-6964	term	_
42-37	6965-6972	signals	_
42-38	6973-6974	.	_

Text=A spike matrix was created from volumes that had high relative FD (> 0.3 mm).
43-1	6975-6976	A	_
43-2	6977-6982	spike	_
43-3	6983-6989	matrix	_
43-4	6990-6993	was	_
43-5	6994-7001	created	_
43-6	7002-7006	from	_
43-7	7007-7014	volumes	_
43-8	7015-7019	that	_
43-9	7020-7023	had	_
43-10	7024-7028	high	_
43-11	7029-7037	relative	_
43-12	7038-7040	FD	_
43-13	7041-7042	(	_
43-14	7043-7044	>	_
43-15	7045-7048	0.3	_
43-16	7049-7051	mm	_
43-17	7052-7053	)	_
43-18	7054-7055	.	_

Text=Then the combination of the 36-parameter matrix and the spike matrix were regressed out of the fMRI signals.
44-1	7056-7060	Then	_
44-2	7061-7064	the	_
44-3	7065-7076	combination	_
44-4	7077-7079	of	_
44-5	7080-7083	the	_
44-6	7084-7096	36-parameter	_
44-7	7097-7103	matrix	_
44-8	7104-7107	and	_
44-9	7108-7111	the	_
44-10	7112-7117	spike	_
44-11	7118-7124	matrix	_
44-12	7125-7129	were	_
44-13	7130-7139	regressed	_
44-14	7140-7143	out	_
44-15	7144-7146	of	_
44-16	7147-7150	the	_
44-17	7151-7155	fMRI	_
44-18	7156-7163	signals	_
44-19	7164-7165	.	_

Text=Datasets with spike volumes longer than 4 min (i.e., less than 4 min of low-motion data) were excluded from the study.
45-1	7166-7174	Datasets	_
45-2	7175-7179	with	_
45-3	7180-7185	spike	_
45-4	7186-7193	volumes	_
45-5	7194-7200	longer	_
45-6	7201-7205	than	_
45-7	7206-7207	4	_
45-8	7208-7211	min	_
45-9	7212-7213	(	_
45-10	7214-7218	i.e.	_
45-11	7219-7220	,	_
45-12	7221-7225	less	_
45-13	7226-7230	than	_
45-14	7231-7232	4	_
45-15	7233-7236	min	_
45-16	7237-7239	of	_
45-17	7240-7250	low-motion	_
45-18	7251-7255	data	_
45-19	7256-7257	)	_
45-20	7258-7262	were	_
45-21	7263-7271	excluded	_
45-22	7272-7276	from	_
45-23	7277-7280	the	_
45-24	7281-7286	study	_
45-25	7287-7288	.	_

Text=Finally, the residual fMRI signals were band-pass filtered (0.009 to 0.08 Hz), underwent linear-trend removal, spatially transformed to MNI standard space using a pediatric template aged from 4.5 to 8.5 years, and spatially smoothed with a 4 mm full width at half maximum kernel.
46-1	7289-7296	Finally	_
46-2	7297-7298	,	_
46-3	7299-7302	the	_
46-4	7303-7311	residual	_
46-5	7312-7316	fMRI	_
46-6	7317-7324	signals	_
46-7	7325-7329	were	_
46-8	7330-7339	band-pass	_
46-9	7340-7348	filtered	_
46-10	7349-7350	(	_
46-11	7351-7356	0.009	_
46-12	7357-7359	to	_
46-13	7360-7364	0.08	_
46-14	7365-7367	Hz	_
46-15	7368-7369	)	_
46-16	7370-7371	,	_
46-17	7372-7381	underwent	_
46-18	7382-7394	linear-trend	_
46-19	7395-7402	removal	_
46-20	7403-7404	,	_
46-21	7405-7414	spatially	_
46-22	7415-7426	transformed	_
46-23	7427-7429	to	_
46-24	7430-7433	MNI	_
46-25	7434-7442	standard	_
46-26	7443-7448	space	_
46-27	7449-7454	using	_
46-28	7455-7456	a	_
46-29	7457-7466	pediatric	_
46-30	7467-7475	template	_
46-31	7476-7480	aged	_
46-32	7481-7485	from	_
46-33	7486-7489	4.5	_
46-34	7490-7492	to	_
46-35	7493-7496	8.5	_
46-36	7497-7502	years	_
46-37	7503-7504	,	_
46-38	7505-7508	and	_
46-39	7509-7518	spatially	_
46-40	7519-7527	smoothed	_
46-41	7528-7532	with	_
46-42	7533-7534	a	_
46-43	7535-7536	4	_
46-44	7537-7539	mm	_
46-45	7540-7544	full	_
46-46	7545-7550	width	_
46-47	7551-7553	at	_
46-48	7554-7558	half	_
46-49	7559-7566	maximum	_
46-50	7567-7573	kernel	_
46-51	7574-7575	.	_

Text=Slice timing, head motion correction, T1-weighted image segmentation, head motion outlier detection, co-registration, and spatial normalization and smoothing were done in FSL.
47-1	7576-7581	Slice	_
47-2	7582-7588	timing	_
47-3	7589-7590	,	_
47-4	7591-7595	head	_
47-5	7596-7602	motion	_
47-6	7603-7613	correction	_
47-7	7614-7615	,	_
47-8	7616-7627	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
47-9	7628-7633	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
47-10	7634-7646	segmentation	_
47-11	7647-7648	,	_
47-12	7649-7653	head	_
47-13	7654-7660	motion	_
47-14	7661-7668	outlier	_
47-15	7669-7678	detection	_
47-16	7679-7680	,	_
47-17	7681-7696	co-registration	_
47-18	7697-7698	,	_
47-19	7699-7702	and	_
47-20	7703-7710	spatial	_
47-21	7711-7724	normalization	_
47-22	7725-7728	and	_
47-23	7729-7738	smoothing	_
47-24	7739-7743	were	_
47-25	7744-7748	done	_
47-26	7749-7751	in	_
47-27	7752-7755	FSL	_
47-28	7756-7757	.	_

Text=Regression of the nuisance signals, band-pass filtering and linear trend removal were done using AFNI version AFNI_17.3.03.
48-1	7758-7768	Regression	_
48-2	7769-7771	of	_
48-3	7772-7775	the	_
48-4	7776-7784	nuisance	_
48-5	7785-7792	signals	_
48-6	7793-7794	,	_
48-7	7795-7804	band-pass	_
48-8	7805-7814	filtering	_
48-9	7815-7818	and	_
48-10	7819-7825	linear	_
48-11	7826-7831	trend	_
48-12	7832-7839	removal	_
48-13	7840-7844	were	_
48-14	7845-7849	done	_
48-15	7850-7855	using	_
48-16	7856-7860	AFNI	_
48-17	7861-7868	version	_
48-18	7869-7881	AFNI_17.3.03	_
48-19	7882-7883	.	_

Text=Functional connectome constructions We used an adapted version of the stability analysis performed by Vanderwal and colleagues to investigate intra-individual stability of the functional connectome.
49-1	7884-7894	Functional	_
49-2	7895-7905	connectome	_
49-3	7906-7919	constructions	_
49-4	7920-7922	We	_
49-5	7923-7927	used	_
49-6	7928-7930	an	_
49-7	7931-7938	adapted	_
49-8	7939-7946	version	_
49-9	7947-7949	of	_
49-10	7950-7953	the	_
49-11	7954-7963	stability	_
49-12	7964-7972	analysis	_
49-13	7973-7982	performed	_
49-14	7983-7985	by	_
49-15	7986-7995	Vanderwal	_
49-16	7996-7999	and	_
49-17	8000-8010	colleagues	_
49-18	8011-8013	to	_
49-19	8014-8025	investigate	_
49-20	8026-8042	intra-individual	_
49-21	8043-8052	stability	_
49-22	8053-8055	of	_
49-23	8056-8059	the	_
49-24	8060-8070	functional	_
49-25	8071-8081	connectome	_
49-26	8082-8083	.	_

Text=This analysis involved splitting the fMRI signal into two halves for each participant and comparing the similarity between halves.
50-1	8084-8088	This	_
50-2	8089-8097	analysis	_
50-3	8098-8106	involved	_
50-4	8107-8116	splitting	_
50-5	8117-8120	the	_
50-6	8121-8125	fMRI	_
50-7	8126-8132	signal	_
50-8	8133-8137	into	_
50-9	8138-8141	two	_
50-10	8142-8148	halves	_
50-11	8149-8152	for	_
50-12	8153-8157	each	_
50-13	8158-8169	participant	_
50-14	8170-8173	and	_
50-15	8174-8183	comparing	_
50-16	8184-8187	the	_
50-17	8188-8198	similarity	_
50-18	8199-8206	between	_
50-19	8207-8213	halves	_
50-20	8214-8215	.	_

Text=To complete this, each participant's fMRI time series was split into two equal datasets with 120 time points each.
51-1	8216-8218	To	_
51-2	8219-8227	complete	_
51-3	8228-8232	this	_
51-4	8233-8234	,	_
51-5	8235-8239	each	_
51-6	8240-8251	participant	_
51-7	8252-8254	's	_
51-8	8255-8259	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
51-9	8260-8264	time	_
51-10	8265-8271	series	_
51-11	8272-8275	was	_
51-12	8276-8281	split	_
51-13	8282-8286	into	_
51-14	8287-8290	two	_
51-15	8291-8296	equal	_
51-16	8297-8305	datasets	_
51-17	8306-8310	with	_
51-18	8311-8314	120	_
51-19	8315-8319	time	_
51-20	8320-8326	points	_
51-21	8327-8331	each	_
51-22	8332-8333	.	_

Text=Each half of the dataset, as well as the entire dataset (all time points), were separately run through the following functional connectome analysis in AFNI.
52-1	8334-8338	Each	_
52-2	8339-8343	half	_
52-3	8344-8346	of	_
52-4	8347-8350	the	_
52-5	8351-8358	dataset	_
52-6	8359-8360	,	_
52-7	8361-8363	as	_
52-8	8364-8368	well	_
52-9	8369-8371	as	_
52-10	8372-8375	the	_
52-11	8376-8382	entire	_
52-12	8383-8390	dataset	_
52-13	8391-8392	(	_
52-14	8393-8396	all	_
52-15	8397-8401	time	_
52-16	8402-8408	points	_
52-17	8409-8410	)	_
52-18	8411-8412	,	_
52-19	8413-8417	were	_
52-20	8418-8428	separately	_
52-21	8429-8432	run	_
52-22	8433-8440	through	_
52-23	8441-8444	the	_
52-24	8445-8454	following	_
52-25	8455-8465	functional	_
52-26	8466-8476	connectome	_
52-27	8477-8485	analysis	_
52-28	8486-8488	in	_
52-29	8489-8493	AFNI	_
52-30	8494-8495	.	_

Text=The Automated Anatomical Labeling (AAL) template was used to subdivide each participant's brain into 90 regions excluding the cerebellum.
53-1	8496-8499	The	_
53-2	8500-8509	Automated	_
53-3	8510-8520	Anatomical	_
53-4	8521-8529	Labeling	_
53-5	8530-8531	(	_
53-6	8532-8535	AAL	_
53-7	8536-8537	)	_
53-8	8538-8546	template	_
53-9	8547-8550	was	_
53-10	8551-8555	used	_
53-11	8556-8558	to	_
53-12	8559-8568	subdivide	_
53-13	8569-8573	each	_
53-14	8574-8585	participant	_
53-15	8586-8588	's	_
53-16	8589-8594	brain	_
53-17	8595-8599	into	_
53-18	8600-8602	90	_
53-19	8603-8610	regions	_
53-20	8611-8620	excluding	_
53-21	8621-8624	the	_
53-22	8625-8635	cerebellum	_
53-23	8636-8637	.	_

Text=The average time series was calculated within each AAL region, and then Pearson's correlation coefficients were calculated between the averaged time series of each pair of AAL regions and transformed to Fisher's z scores to create a 90 × 90 connectivity matrix for each dataset (Fig.
54-1	8638-8641	The	_
54-2	8642-8649	average	_
54-3	8650-8654	time	_
54-4	8655-8661	series	_
54-5	8662-8665	was	_
54-6	8666-8676	calculated	_
54-7	8677-8683	within	_
54-8	8684-8688	each	_
54-9	8689-8692	AAL	_
54-10	8693-8699	region	_
54-11	8700-8701	,	_
54-12	8702-8705	and	_
54-13	8706-8710	then	_
54-14	8711-8718	Pearson	_
54-15	8719-8721	's	_
54-16	8722-8733	correlation	_
54-17	8734-8746	coefficients	_
54-18	8747-8751	were	_
54-19	8752-8762	calculated	_
54-20	8763-8770	between	_
54-21	8771-8774	the	_
54-22	8775-8783	averaged	_
54-23	8784-8788	time	_
54-24	8789-8795	series	_
54-25	8796-8798	of	_
54-26	8799-8803	each	_
54-27	8804-8808	pair	_
54-28	8809-8811	of	_
54-29	8812-8815	AAL	_
54-30	8816-8823	regions	_
54-31	8824-8827	and	_
54-32	8828-8839	transformed	_
54-33	8840-8842	to	_
54-34	8843-8849	Fisher	_
54-35	8850-8852	's	_
54-36	8853-8854	z	_
54-37	8855-8861	scores	_
54-38	8862-8864	to	_
54-39	8865-8871	create	_
54-40	8872-8873	a	_
54-41	8874-8876	90	_
54-42	8877-8878	×	_
54-43	8879-8881	90	_
54-44	8882-8894	connectivity	_
54-45	8895-8901	matrix	_
54-46	8902-8905	for	_
54-47	8906-8910	each	_
54-48	8911-8918	dataset	_
54-49	8919-8920	(	_
54-50	8921-8924	Fig	_
54-51	8925-8926	.	_

Text=1a).
55-1	8927-8929	1a	_
55-2	8930-8931	)	_
55-3	8932-8933	.	_

Text=Thus, three connectivity matrices were produced for each participant: one on the first half of their data, one on the second half, and one for the entire dataset.
56-1	8934-8938	Thus	_
56-2	8939-8940	,	_
56-3	8941-8946	three	_
56-4	8947-8959	connectivity	_
56-5	8960-8968	matrices	_
56-6	8969-8973	were	_
56-7	8974-8982	produced	_
56-8	8983-8986	for	_
56-9	8987-8991	each	_
56-10	8992-9003	participant	_
56-11	9004-9005	:	_
56-12	9006-9009	one	_
56-13	9010-9012	on	_
56-14	9013-9016	the	_
56-15	9017-9022	first	_
56-16	9023-9027	half	_
56-17	9028-9030	of	_
56-18	9031-9036	their	_
56-19	9037-9041	data	_
56-20	9042-9043	,	_
56-21	9044-9047	one	_
56-22	9048-9050	on	_
56-23	9051-9054	the	_
56-24	9055-9061	second	_
56-25	9062-9066	half	_
56-26	9067-9068	,	_
56-27	9069-9072	and	_
56-28	9073-9076	one	_
56-29	9077-9080	for	_
56-30	9081-9084	the	_
56-31	9085-9091	entire	_
56-32	9092-9099	dataset	_
56-33	9100-9101	.	_

Text=Analysis of the functional connectome First, we examined intra-participant stability during movie watching by correlating connectivity matrices from the first and the second halves of the dataset for each participant (Fig.
57-1	9102-9110	Analysis	_
57-2	9111-9113	of	_
57-3	9114-9117	the	_
57-4	9118-9128	functional	_
57-5	9129-9139	connectome	_
57-6	9140-9145	First	_
57-7	9146-9147	,	_
57-8	9148-9150	we	_
57-9	9151-9159	examined	_
57-10	9160-9177	intra-participant	_
57-11	9178-9187	stability	_
57-12	9188-9194	during	_
57-13	9195-9200	movie	_
57-14	9201-9209	watching	_
57-15	9210-9212	by	_
57-16	9213-9224	correlating	_
57-17	9225-9237	connectivity	_
57-18	9238-9246	matrices	_
57-19	9247-9251	from	_
57-20	9252-9255	the	_
57-21	9256-9261	first	_
57-22	9262-9265	and	_
57-23	9266-9269	the	_
57-24	9270-9276	second	_
57-25	9277-9283	halves	_
57-26	9284-9286	of	_
57-27	9287-9290	the	_
57-28	9291-9298	dataset	_
57-29	9299-9302	for	_
57-30	9303-9307	each	_
57-31	9308-9319	participant	_
57-32	9320-9321	(	_
57-33	9322-9325	Fig	_
57-34	9326-9327	.	_

Text=1a).
58-1	9328-9330	1a	_
58-2	9331-9332	)	_
58-3	9333-9334	.	_

Text=Correlation coefficients were transformed to Fisher's z scores and a permutation comparison test was performed between the PAE and control groups.
59-1	9335-9346	Correlation	_
59-2	9347-9359	coefficients	_
59-3	9360-9364	were	_
59-4	9365-9376	transformed	_
59-5	9377-9379	to	_
59-6	9380-9386	Fisher	_
59-7	9387-9389	's	_
59-8	9390-9391	z	_
59-9	9392-9398	scores	_
59-10	9399-9402	and	_
59-11	9403-9404	a	_
59-12	9405-9416	permutation	_
59-13	9417-9427	comparison	_
59-14	9428-9432	test	_
59-15	9433-9436	was	_
59-16	9437-9446	performed	_
59-17	9447-9454	between	_
59-18	9455-9458	the	_
59-19	9459-9462	PAE	_
59-20	9463-9466	and	_
59-21	9467-9474	control	_
59-22	9475-9481	groups	_
59-23	9482-9483	.	_

Text=Age, sex, head motion (i.e., averaged relative FD), and total brain volume were included as covariates.
60-1	9484-9487	Age	_
60-2	9488-9489	,	_
60-3	9490-9493	sex	_
60-4	9494-9495	,	_
60-5	9496-9500	head	_
60-6	9501-9507	motion	_
60-7	9508-9509	(	_
60-8	9510-9514	i.e.	_
60-9	9515-9516	,	_
60-10	9517-9525	averaged	_
60-11	9526-9534	relative	_
60-12	9535-9537	FD	_
60-13	9538-9539	)	_
60-14	9540-9541	,	_
60-15	9542-9545	and	_
60-16	9546-9551	total	_
60-17	9552-9557	brain	_
60-18	9558-9564	volume	_
60-19	9565-9569	were	_
60-20	9570-9578	included	_
60-21	9579-9581	as	_
60-22	9582-9592	covariates	_
60-23	9593-9594	.	_

Text=Linear correlations between age and the intra-participant stability metric were calculated for each group with sex, head motion, and total brain volume as covariates.
61-1	9595-9601	Linear	_
61-2	9602-9614	correlations	_
61-3	9615-9622	between	_
61-4	9623-9626	age	_
61-5	9627-9630	and	_
61-6	9631-9634	the	_
61-7	9635-9652	intra-participant	_
61-8	9653-9662	stability	_
61-9	9663-9669	metric	_
61-10	9670-9674	were	_
61-11	9675-9685	calculated	_
61-12	9686-9689	for	_
61-13	9690-9694	each	_
61-14	9695-9700	group	_
61-15	9701-9705	with	_
61-16	9706-9709	sex	_
61-17	9710-9711	,	_
61-18	9712-9716	head	_
61-19	9717-9723	motion	_
61-20	9724-9725	,	_
61-21	9726-9729	and	_
61-22	9730-9735	total	_
61-23	9736-9741	brain	_
61-24	9742-9748	volume	_
61-25	9749-9751	as	_
61-26	9752-9762	covariates	_
61-27	9763-9764	.	_

Text=Second, inter-individual stability was examined within each group (Fig.
62-1	9765-9771	Second	_
62-2	9772-9773	,	_
62-3	9774-9790	inter-individual	_
62-4	9791-9800	stability	_
62-5	9801-9804	was	_
62-6	9805-9813	examined	_
62-7	9814-9820	within	_
62-8	9821-9825	each	_
62-9	9826-9831	group	_
62-10	9832-9833	(	_
62-11	9834-9837	Fig	_
62-12	9838-9839	.	_

Text=1b).
63-1	9840-9842	1b	_
63-2	9843-9844	)	_
63-3	9845-9846	.	_

Text=Pearson's correlation coefficients were calculated between each subject's whole connectivity matrix and that of every other participant in the same group (i.e., PAE or controls).
64-1	9847-9854	Pearson	_
64-2	9855-9857	's	_
64-3	9858-9869	correlation	_
64-4	9870-9882	coefficients	_
64-5	9883-9887	were	_
64-6	9888-9898	calculated	_
64-7	9899-9906	between	_
64-8	9907-9911	each	_
64-9	9912-9919	subject	_
64-10	9920-9922	's	_
64-11	9923-9928	whole	_
64-12	9929-9941	connectivity	_
64-13	9942-9948	matrix	_
64-14	9949-9952	and	_
64-15	9953-9957	that	_
64-16	9958-9960	of	_
64-17	9961-9966	every	_
64-18	9967-9972	other	_
64-19	9973-9984	participant	_
64-20	9985-9987	in	_
64-21	9988-9991	the	_
64-22	9992-9996	same	_
64-23	9997-10002	group	_
64-24	10003-10004	(	_
64-25	10005-10009	i.e.	_
64-26	10010-10011	,	_
64-27	10012-10015	PAE	_
64-28	10016-10018	or	_
64-29	10019-10027	controls	_
64-30	10028-10029	)	_
64-31	10030-10031	.	_

Text=Then a 215 × 215 correlation matrix for the unexposed control group and a 34 × 34 correlation matrix for the PAE group were generated, and the average value of each row was calculated to generate an inter-individual stability value for each person in each dataset.
65-1	10032-10036	Then	_
65-2	10037-10038	a	_
65-3	10039-10042	215	_
65-4	10043-10044	×	_
65-5	10045-10048	215	_
65-6	10049-10060	correlation	_
65-7	10061-10067	matrix	_
65-8	10068-10071	for	_
65-9	10072-10075	the	_
65-10	10076-10085	unexposed	_
65-11	10086-10093	control	_
65-12	10094-10099	group	_
65-13	10100-10103	and	_
65-14	10104-10105	a	_
65-15	10106-10108	34	_
65-16	10109-10110	×	_
65-17	10111-10113	34	_
65-18	10114-10125	correlation	_
65-19	10126-10132	matrix	_
65-20	10133-10136	for	_
65-21	10137-10140	the	_
65-22	10141-10144	PAE	_
65-23	10145-10150	group	_
65-24	10151-10155	were	_
65-25	10156-10165	generated	_
65-26	10166-10167	,	_
65-27	10168-10171	and	_
65-28	10172-10175	the	_
65-29	10176-10183	average	_
65-30	10184-10189	value	_
65-31	10190-10192	of	_
65-32	10193-10197	each	_
65-33	10198-10201	row	_
65-34	10202-10205	was	_
65-35	10206-10216	calculated	_
65-36	10217-10219	to	_
65-37	10220-10228	generate	_
65-38	10229-10231	an	_
65-39	10232-10248	inter-individual	_
65-40	10249-10258	stability	_
65-41	10259-10264	value	_
65-42	10265-10268	for	_
65-43	10269-10273	each	_
65-44	10274-10280	person	_
65-45	10281-10283	in	_
65-46	10284-10288	each	_
65-47	10289-10296	dataset	_
65-48	10297-10298	.	_

Text=A permutation comparison test was performed between the inter-individual stability of two groups with age, sex, head motion, and total brain volume as covariates.
66-1	10299-10300	A	_
66-2	10301-10312	permutation	_
66-3	10313-10323	comparison	_
66-4	10324-10328	test	_
66-5	10329-10332	was	_
66-6	10333-10342	performed	_
66-7	10343-10350	between	_
66-8	10351-10354	the	_
66-9	10355-10371	inter-individual	_
66-10	10372-10381	stability	_
66-11	10382-10384	of	_
66-12	10385-10388	two	_
66-13	10389-10395	groups	_
66-14	10396-10400	with	_
66-15	10401-10404	age	_
66-16	10405-10406	,	_
66-17	10407-10410	sex	_
66-18	10411-10412	,	_
66-19	10413-10417	head	_
66-20	10418-10424	motion	_
66-21	10425-10426	,	_
66-22	10427-10430	and	_
66-23	10431-10436	total	_
66-24	10437-10442	brain	_
66-25	10443-10449	volume	_
66-26	10450-10452	as	_
66-27	10453-10463	covariates	_
66-28	10464-10465	.	_

Text=The relationship between inter-individual stability and age was examined with sex, head motion, and total brain volume as covariates.
67-1	10466-10469	The	_
67-2	10470-10482	relationship	_
67-3	10483-10490	between	_
67-4	10491-10507	inter-individual	_
67-5	10508-10517	stability	_
67-6	10518-10521	and	_
67-7	10522-10525	age	_
67-8	10526-10529	was	_
67-9	10530-10538	examined	_
67-10	10539-10543	with	_
67-11	10544-10547	sex	_
67-12	10548-10549	,	_
67-13	10550-10554	head	_
67-14	10555-10561	motion	_
67-15	10562-10563	,	_
67-16	10564-10567	and	_
67-17	10568-10573	total	_
67-18	10574-10579	brain	_
67-19	10580-10586	volume	_
67-20	10587-10589	as	_
67-21	10590-10600	covariates	_
67-22	10601-10602	.	_

Text=Graph-theory based metrics calculation As in previous studies, the graph theoretical measurements were calculated for the thresholded and binarized individual connectivity matrix of the whole time series.
68-1	10603-10615	Graph-theory	_
68-2	10616-10621	based	_
68-3	10622-10629	metrics	_
68-4	10630-10641	calculation	_
68-5	10642-10644	As	_
68-6	10645-10647	in	_
68-7	10648-10656	previous	_
68-8	10657-10664	studies	_
68-9	10665-10666	,	_
68-10	10667-10670	the	_
68-11	10671-10676	graph	_
68-12	10677-10688	theoretical	_
68-13	10689-10701	measurements	_
68-14	10702-10706	were	_
68-15	10707-10717	calculated	_
68-16	10718-10721	for	_
68-17	10722-10725	the	_
68-18	10726-10737	thresholded	_
68-19	10738-10741	and	_
68-20	10742-10751	binarized	_
68-21	10752-10762	individual	_
68-22	10763-10775	connectivity	_
68-23	10776-10782	matrix	_
68-24	10783-10785	of	_
68-25	10786-10789	the	_
68-26	10790-10795	whole	_
68-27	10796-10800	time	_
68-28	10801-10807	series	_
68-29	10808-10809	.	_

Text=The threshold of the matrix was set at r = 0.17 as p <0.01.
69-1	10810-10813	The	_
69-2	10814-10823	threshold	_
69-3	10824-10826	of	_
69-4	10827-10830	the	_
69-5	10831-10837	matrix	_
69-6	10838-10841	was	_
69-7	10842-10845	set	_
69-8	10846-10848	at	_
69-9	10849-10850	r	_
69-10	10851-10852	=	_
69-11	10853-10857	0.17	_
69-12	10858-10860	as	_
69-13	10861-10862	p	_
69-14	10863-10864	<	_
69-15	10865-10869	0.01	_
69-16	10870-10871	.	_

Text=The graph theoretic metrics (global and nodal level of clustering coefficient, shortest path length, small-worldness, local efficiency, global efficiency, betweenness centrality and network degree centrality) were calculated for each binary matrix using the GRETNA toolbox.
70-1	10872-10875	The	_
70-2	10876-10881	graph	_
70-3	10882-10891	theoretic	_
70-4	10892-10899	metrics	_
70-5	10900-10901	(	_
70-6	10902-10908	global	_
70-7	10909-10912	and	_
70-8	10913-10918	nodal	_
70-9	10919-10924	level	_
70-10	10925-10927	of	_
70-11	10928-10938	clustering	_
70-12	10939-10950	coefficient	_
70-13	10951-10952	,	_
70-14	10953-10961	shortest	_
70-15	10962-10966	path	_
70-16	10967-10973	length	_
70-17	10974-10975	,	_
70-18	10976-10991	small-worldness	_
70-19	10992-10993	,	_
70-20	10994-10999	local	_
70-21	11000-11010	efficiency	_
70-22	11011-11012	,	_
70-23	11013-11019	global	_
70-24	11020-11030	efficiency	_
70-25	11031-11032	,	_
70-26	11033-11044	betweenness	_
70-27	11045-11055	centrality	_
70-28	11056-11059	and	_
70-29	11060-11067	network	_
70-30	11068-11074	degree	_
70-31	11075-11085	centrality	_
70-32	11086-11087	)	_
70-33	11088-11092	were	_
70-34	11093-11103	calculated	_
70-35	11104-11107	for	_
70-36	11108-11112	each	_
70-37	11113-11119	binary	_
70-38	11120-11126	matrix	_
70-39	11127-11132	using	_
70-40	11133-11136	the	_
70-41	11137-11143	GRETNA	_
70-42	11144-11151	toolbox	_
70-43	11152-11153	.	_

Text=Clustering coefficient measures the connection density among all neighbors of each node; shortest path length measures the fastest pathway to transfer information between any pair of nodes; sigma characterizes the ratio between clustering coefficient and shortest path length compared with the random networks; local efficiency measures the efficiency of transferring information from each node and its neighbors; global efficiency measures the efficiency of transferring information from each node to all other nodes in the whole graph, with higher efficiency indicating that fewer pathways are required to reach to other nodes in the network; betweenness centrality measures the intensity of the shortest pathway that passes each node; degree centrality measures the number of the connections of each node.
71-1	11154-11164	Clustering	_
71-2	11165-11176	coefficient	_
71-3	11177-11185	measures	_
71-4	11186-11189	the	_
71-5	11190-11200	connection	_
71-6	11201-11208	density	_
71-7	11209-11214	among	_
71-8	11215-11218	all	_
71-9	11219-11228	neighbors	_
71-10	11229-11231	of	_
71-11	11232-11236	each	_
71-12	11237-11241	node	_
71-13	11242-11243	;	_
71-14	11244-11252	shortest	_
71-15	11253-11257	path	_
71-16	11258-11264	length	_
71-17	11265-11273	measures	_
71-18	11274-11277	the	_
71-19	11278-11285	fastest	_
71-20	11286-11293	pathway	_
71-21	11294-11296	to	_
71-22	11297-11305	transfer	_
71-23	11306-11317	information	_
71-24	11318-11325	between	_
71-25	11326-11329	any	_
71-26	11330-11334	pair	_
71-27	11335-11337	of	_
71-28	11338-11343	nodes	_
71-29	11344-11345	;	_
71-30	11346-11351	sigma	_
71-31	11352-11365	characterizes	_
71-32	11366-11369	the	_
71-33	11370-11375	ratio	_
71-34	11376-11383	between	_
71-35	11384-11394	clustering	_
71-36	11395-11406	coefficient	_
71-37	11407-11410	and	_
71-38	11411-11419	shortest	_
71-39	11420-11424	path	_
71-40	11425-11431	length	_
71-41	11432-11440	compared	_
71-42	11441-11445	with	_
71-43	11446-11449	the	_
71-44	11450-11456	random	_
71-45	11457-11465	networks	_
71-46	11466-11467	;	_
71-47	11468-11473	local	_
71-48	11474-11484	efficiency	_
71-49	11485-11493	measures	_
71-50	11494-11497	the	_
71-51	11498-11508	efficiency	_
71-52	11509-11511	of	_
71-53	11512-11524	transferring	_
71-54	11525-11536	information	_
71-55	11537-11541	from	_
71-56	11542-11546	each	_
71-57	11547-11551	node	_
71-58	11552-11555	and	_
71-59	11556-11559	its	_
71-60	11560-11569	neighbors	_
71-61	11570-11571	;	_
71-62	11572-11578	global	_
71-63	11579-11589	efficiency	_
71-64	11590-11598	measures	_
71-65	11599-11602	the	_
71-66	11603-11613	efficiency	_
71-67	11614-11616	of	_
71-68	11617-11629	transferring	_
71-69	11630-11641	information	_
71-70	11642-11646	from	_
71-71	11647-11651	each	_
71-72	11652-11656	node	_
71-73	11657-11659	to	_
71-74	11660-11663	all	_
71-75	11664-11669	other	_
71-76	11670-11675	nodes	_
71-77	11676-11678	in	_
71-78	11679-11682	the	_
71-79	11683-11688	whole	_
71-80	11689-11694	graph	_
71-81	11695-11696	,	_
71-82	11697-11701	with	_
71-83	11702-11708	higher	_
71-84	11709-11719	efficiency	_
71-85	11720-11730	indicating	_
71-86	11731-11735	that	_
71-87	11736-11741	fewer	_
71-88	11742-11750	pathways	_
71-89	11751-11754	are	_
71-90	11755-11763	required	_
71-91	11764-11766	to	_
71-92	11767-11772	reach	_
71-93	11773-11775	to	_
71-94	11776-11781	other	_
71-95	11782-11787	nodes	_
71-96	11788-11790	in	_
71-97	11791-11794	the	_
71-98	11795-11802	network	_
71-99	11803-11804	;	_
71-100	11805-11816	betweenness	_
71-101	11817-11827	centrality	_
71-102	11828-11836	measures	_
71-103	11837-11840	the	_
71-104	11841-11850	intensity	_
71-105	11851-11853	of	_
71-106	11854-11857	the	_
71-107	11858-11866	shortest	_
71-108	11867-11874	pathway	_
71-109	11875-11879	that	_
71-110	11880-11886	passes	_
71-111	11887-11891	each	_
71-112	11892-11896	node	_
71-113	11897-11898	;	_
71-114	11899-11905	degree	_
71-115	11906-11916	centrality	_
71-116	11917-11925	measures	_
71-117	11926-11929	the	_
71-118	11930-11936	number	_
71-119	11937-11939	of	_
71-120	11940-11943	the	_
71-121	11944-11955	connections	_
71-122	11956-11958	of	_
71-123	11959-11963	each	_
71-124	11964-11968	node	_
71-125	11969-11970	.	_

Text=Permutation tests between the two groups for each metric were performed controlling for age, sex, head motion, and total brain volume.
72-1	11971-11982	Permutation	_
72-2	11983-11988	tests	_
72-3	11989-11996	between	_
72-4	11997-12000	the	_
72-5	12001-12004	two	_
72-6	12005-12011	groups	_
72-7	12012-12015	for	_
72-8	12016-12020	each	_
72-9	12021-12027	metric	_
72-10	12028-12032	were	_
72-11	12033-12042	performed	_
72-12	12043-12054	controlling	_
72-13	12055-12058	for	_
72-14	12059-12062	age	_
72-15	12063-12064	,	_
72-16	12065-12068	sex	_
72-17	12069-12070	,	_
72-18	12071-12075	head	_
72-19	12076-12082	motion	_
72-20	12083-12084	,	_
72-21	12085-12088	and	_
72-22	12089-12094	total	_
72-23	12095-12100	brain	_
72-24	12101-12107	volume	_
72-25	12108-12109	.	_

Text=The threshold for nodal metrics was set at p <0.05.
73-1	12110-12113	The	_
73-2	12114-12123	threshold	_
73-3	12124-12127	for	_
73-4	12128-12133	nodal	_
73-5	12134-12141	metrics	_
73-6	12142-12145	was	_
73-7	12146-12149	set	_
73-8	12150-12152	at	_
73-9	12153-12154	p	_
73-10	12155-12156	<	_
73-11	12157-12161	0.05	_
73-12	12162-12163	.	_

Text=For completeness, we report results both uncorrected and corrected using false discovery rate (FDR) for multiple comparisons.
74-1	12164-12167	For	_
74-2	12168-12180	completeness	_
74-3	12181-12182	,	_
74-4	12183-12185	we	_
74-5	12186-12192	report	_
74-6	12193-12200	results	_
74-7	12201-12205	both	_
74-8	12206-12217	uncorrected	_
74-9	12218-12221	and	_
74-10	12222-12231	corrected	_
74-11	12232-12237	using	_
74-12	12238-12243	false	_
74-13	12244-12253	discovery	_
74-14	12254-12258	rate	_
74-15	12259-12260	(	_
74-16	12261-12264	FDR	_
74-17	12265-12266	)	_
74-18	12267-12270	for	_
74-19	12271-12279	multiple	_
74-20	12280-12291	comparisons	_
74-21	12292-12293	.	_

Text=We also analyzed metrics for linear correlations with age, and for group-age interactions.
75-1	12294-12296	We	_
75-2	12297-12301	also	_
75-3	12302-12310	analyzed	_
75-4	12311-12318	metrics	_
75-5	12319-12322	for	_
75-6	12323-12329	linear	_
75-7	12330-12342	correlations	_
75-8	12343-12347	with	_
75-9	12348-12351	age	_
75-10	12352-12353	,	_
75-11	12354-12357	and	_
75-12	12358-12361	for	_
75-13	12362-12371	group-age	_
75-14	12372-12384	interactions	_
75-15	12385-12386	.	_

Text=All permutation tests were performed in the GRETNA toolbox.
76-1	12387-12390	All	_
76-2	12391-12402	permutation	_
76-3	12403-12408	tests	_
76-4	12409-12413	were	_
76-5	12414-12423	performed	_
76-6	12424-12426	in	_
76-7	12427-12430	the	_
76-8	12431-12437	GRETNA	_
76-9	12438-12445	toolbox	_
76-10	12446-12447	.	_

Text=The nodal level results were displayed by BrainNet Viewer toolbox.
77-1	12448-12451	The	_
77-2	12452-12457	nodal	_
77-3	12458-12463	level	_
77-4	12464-12471	results	_
77-5	12472-12476	were	_
77-6	12477-12486	displayed	_
77-7	12487-12489	by	_
77-8	12490-12498	BrainNet	_
77-9	12499-12505	Viewer	_
77-10	12506-12513	toolbox	_
77-11	12514-12515	.	_

